Vienna Life Science Report 2015/16(pdf/12 MB)

232 Pages·2016·12.31 MB·English

(cid:42)(cid:42)(cid:86)(cid:86)(cid:85)(cid:85)(cid:85)(cid:85)(cid:42)(cid:76)(cid:76)(cid:74)(cid:74)(cid:86)(cid:91)(cid:91)(cid:85)(cid:80)(cid:80)(cid:85)(cid:85)(cid:85)(cid:78)(cid:78)(cid:76)(cid:3)(cid:3)(cid:74)(cid:51)(cid:51)(cid:91)(cid:80)(cid:80)(cid:77)(cid:80)(cid:77)(cid:85)(cid:76)(cid:76)(cid:78)(cid:3)(cid:3)(cid:58)(cid:58)(cid:3)(cid:51)(cid:74)(cid:74)(cid:80)(cid:80)(cid:77)(cid:80)(cid:76)(cid:76)(cid:76)(cid:85)(cid:85)(cid:3)(cid:58)(cid:74)(cid:74)(cid:76)(cid:74)(cid:76)(cid:90)(cid:80)(cid:90)(cid:76)(cid:85)(cid:74)(cid:76)(cid:90)
2015/16
6
1
/
5
1
0
2

T
R
O
P
E
R

E
C
N
E
I
C
S

E
F
I
L

A
N
N
E
I
V
(cid:47)(cid:47)(cid:44)(cid:44)(cid:54)(cid:54)(cid:36)(cid:36)(cid:3)(cid:3)(cid:53)(cid:53)(cid:72)(cid:72)(cid:47)(cid:83)(cid:83)(cid:44)(cid:82)(cid:54)(cid:82)(cid:85)(cid:85)(cid:36)(cid:87)(cid:87)(cid:3)(cid:3)(cid:38)(cid:3)(cid:38)(cid:53)(cid:82)(cid:82)(cid:72)(cid:89)(cid:89)(cid:83)(cid:72)(cid:72)(cid:82)(cid:85)(cid:85)(cid:3)(cid:85)(cid:3)(cid:39)(cid:87)(cid:39)(cid:3)(cid:38)(cid:54)(cid:54)(cid:17)(cid:82)(cid:17)(cid:76)(cid:81)(cid:76)(cid:89)(cid:81)(cid:71)(cid:72)(cid:71)(cid:71)(cid:85)(cid:71)(cid:3)(cid:3)(cid:39)(cid:3)(cid:3)(cid:3)(cid:3)(cid:3)(cid:54)(cid:20)(cid:20)(cid:17)(cid:76)(cid:81)(cid:71)(cid:71)(cid:3)(cid:3)(cid:3)(cid:20) (cid:20)(cid:20)(cid:23)(cid:23)(cid:17)(cid:17)(cid:19)(cid:19)(cid:27)(cid:27)(cid:17)(cid:17)(cid:20)(cid:20)(cid:22)(cid:22)(cid:20)(cid:3)(cid:3)(cid:3)(cid:23)(cid:3)(cid:3)(cid:3)(cid:19)(cid:17)(cid:19)(cid:19)(cid:28)(cid:28)(cid:27)(cid:29)(cid:29)(cid:22)(cid:17)(cid:22)(cid:20)(cid:20)(cid:20)(cid:22)(cid:3)(cid:3)(cid:3)(cid:19)(cid:28)(cid:29)(cid:22)(cid:20)
Imprint
This report is based on data obtained through the evaluation of a written survey among Austria's
life science companies carried out by BIOCOM AG, Vienna in close cooperation with austria wirt-
schaftsservice and LISAvienna in spring 2015. For more information please refer to page 214ff.
The editorial staff comprises Simone Ding, Sandra Wirsching, Dr. Bernd Kaltwaßer (BIOCOM) and
Brigitte Tempelmaier, Peter Halwachs and Johannes Sarx (LISAvienna). The layout was designed by
Benjamin Röbig (BIOCOM). We thank all companies supporting this survey! The layout, graphics and
other contents of this brochure of the Viennese life science cluster are protected by copyright law.
Berlin, October, 2015
The Vienna Life Science Report 2015/2016 is available online at www.LISAvienna.at.
Order your free print copy via e-mail to [email protected].
Contact:
LISAvienna, Walcherstr. 11A, A-1020 Vienna, www.LISAvienna.at
BIOCOM AG, Mariahilfer Str. 95/14, A-1060 Vienna, www.biocom.at
Get connected and follow us at
Xing LinkedIn Twitter ISSUU Flickr
Vienna Life Science Report 2015/16 Preface
Life Sciences, like biotechnology, pharma and medical Life sciences, one of the best success stories in the
devices are strongly represented in Austria as an industry Vienna business world!
as well as in research and development.
The industry has developed enormously in recent years. In
The life science scene is of high economic importance for the addition to providing attractive jobs and training opportuni-
entire society and plays an essential role in a well-functioning ties, it generates an annual income of almost ten billion euros.
healthcare system. In recent years, the strength of Austria’s and Overall, over 35.730 people work at 480 companies, research
especially Vienna’s growing life science sector has been reflect- institutions and other organizations in the field of life sciences
ed in the increasing interest shown by international business in in Vienna. In regard to the total number of companies, research
entering partnerships with companies and research institutions institutions and other organizations in the life sciences, there is a
in Austria. Austrian higher education institutions, non-university plus of 19% when compared with 2012.
research institutions as well as enterprises are showing multiple
outstanding achievements in basic and applied research. The The city of Vienna recognized the future opportunities in the area of
ongoing “Year of Research“ in Austria proves that innovation, life sciences early on and supported development with its location
creativity and qualification are the key for success in competi- and funding policy. Since 1997, we have awarded more than 225
tiveness and social development. Graz, Innsbruck and Vienna million euros to companies and research organizations predomi-
are Austria’s most important cities regarding life sciences. Strong nantly through the Vienna Business Agency and the Vienna Science
ties between federal and regional support structures are in place and Technology Fund and invested further funds into the infrastruc-
to assure close cooperation and balanced assistance. ture. These various measures have contributed to the impressive
development of the life sciences scene in Vienna and internationally.
Compared to the last report two years ago the Austrian life sci-
ence industry has advanced significantly: the number of Austrian Today Vienna offers ideal conditions for biotechnology and medical
life science companies has risen to 823 (+13.8%) and the technology companies from around the world. Vienna is a popular
turnover increased to 19.1 billion euros (+7.8%). In particular, the research and innovation center in Europe and is especially liked
number of dedicated biotech companies increased significantly because of the excellent combination of academic and entre-
by 22% within the last two years. The fruitful cooperation be- preneurial research. The city of Vienna and the Vienna Business
tween science and economy continuously proves that Austria is Agency support and assist companies located in Vienna to be able
a good location for both small and large companies interested in to research and develop at the highest scientific level. They have
sharing its success, thus making Austria a leading destination for been successful: in the past 15 years, the number of research-
life sciences. And the Federal Ministry of Science, Research and based companies in Vienna has increased by 300 percent.
Economy is incessantly committed in improving and optimizing
the strategic framework conditions for a sector up-and-coming! Our aim is to further expand and establish the power of this loca-
tion. That way we ensure quality jobs for the future and develop
Vienna as a leading European center for research and innovation.
Ringhofer
Hans mer
© BMWFW / © Ingo Pertra
Reinhold Mitterlehner Renate Brauner
Vice-Chancellor Vice-Mayor and Vice-Governor of Vienna
and Federal Minister Executive City Councillor of Finance,
for Science, Research and Economy Economic Affairs and Public Utilities
1
2
Vienna Life Science Report 2015/16 Preface
It requires an innovative business plan, a strong IPR position, Innovation is one of the foundations for long-term economic
the best possible team and consistent support to become a success, especially in the life sciences sector, the industry of
success story in the area of the life sciences. the future.
Austria’s federal promotional bank, the Austria Wirtschaftsservice It is a key factor in a stable and strong economy. Only through the
(aws) was commissioned by the Austrian Ministry of Science, implementation of innovative ideas will it be possible to remain
Research and Economy, to aid life science start-ups through internationally competitive and develop sustainably for the benefit of
customized programs. Through LISA (Life Science Austria) we offer the company itself and the city of Vienna.
a one-stop-shop support program to start-ups. You are invited
to evaluate and advance your business idea through our Best of The Vienna Business Agency supports Viennese life sciences
Biotech business plan competition and the s(p)eed dating op- companies in trying new things and successfully implementing their
portunities we offer. This is the first step to profit from our in-house ideas. We assist companies in any business phase with individual
know-how, to receive financial support and to access the extensive consulting, funding and a high quality research infrastructure.
aws network of life sciences managers, legal experts and private Strengthening the networking of companies, research institutions
equity investors. At aws, financial incentives are combined with and competence centers for excellent technologies are also a key
advisory measures, training and internationalization actions, in order focus point.
to guide start-ups to economic independence as early as possible.
aws PreSeed and aws Seedfinancing are among the most impor- As part of the LISAvienna initiative, the Vienna Business Agency
tant founding grants for the high tech industry in Austria. We enjoy also offers its own platform for companies in the pharmaceutical
assisting creative founders through the challenging start-up phase industry, biotechnology and medical device business in coopera-
and to making innovative ideas ready for the worldwide markets. tion with the Austria Wirtschaftsservice GmbH (aws). It advises life
By providing low-interest loans, guarantees, subsidies and equity sciences companies in their creation phase, provides networking
capital, we support company growth and internationalization. opportunities and serves as a central knowledge center for the life
science sector.
The life sciences are booming, and LISAvienna as a successfully
operating life science platform is supporting the enormous potential The aim of all our activities and measures is to support research
in this area. Marketable innovations not only support growth and companies and institutions in creating added value and quality em-
employment, but also benefit the whole of society for example by ployment and thus guaranteeing and expanding the high quality of
assisting potential medical advancements. As a promotional bank, life in Vienna. This not only increases the international attractiveness
it is our goal to accompany start-ups on their path to success and of the location, but is also another big step towards becoming one
thereby further strengthen the position of life sciences in Austria.
Rigaud
Peter
© aws / Ludwig Rusch © Vienna Business Agency /
Bernhard Sagmeister and Edeltraud Stiftinger Gerhard Hirczi
Managing Directors Managing Director
Austria Wirtschaftsservice GmbH Vienna Business Agency
3
4
Vienna Life Science Report 2015/16 Preface
Dear Readers!
Four years ago, we had the pleasure to present the very first Vienna Life Science Report summarizing vital key facts and a directory.
After the update in 2012, we are happy to provide you with a completely revised and extended version of the report now. During the last
months, hundreds of questionnaires have been filled, a multitude of statistical analyses performed and many unseen hours invested into
the most comprehensive directory on life sciences in Vienna that has ever existed.
Our report shows that Vienna is currently experiencing a wave of new start-ups. 30 life sciences companies opened their doors within
the last two years, thereof 20 biotechnology and medical device companies active in in the fields of research, development and manufac-
turing. In 2014, a total of 480 organizations employed 35,730 people in the life sciences in Vienna. This represents a significant growth
as compared to 2012.
We thank all those who contributed behind the scenes in making our new report such a powerful resource for demonstrating the dy-
namics of the life sciences in Vienna. First and foremost we want to mention our long-standing partner BIOCOM whose dedication and
striving for the highest possible data quality allowed us to showcase the significant growth of this sector. The continued collaboration
with LISA international marketing including the joint survey was a key advantage to make Vienna’s facts and figures on the life sciences
comparable to those available for all of Austria. And last but not least, an acknowledgement goes out to all the companies, research
institutes and other organizations that took the time to contribute their data and texts that enabled us to come up with a well grounded
portrait of life sciences in Vienna. Lots of up-to-date facts and figures and interesting examples are included.
As part of the report, you will learn that most of the 67 dedicated biotech companies in Vienna focus on drug development and diag-
nostics. Infectious diseases, cancer and diseases of the respiratory system take center stage. A total of 26 drug candidates are in their
clinical pipelines. Moreover, 48 preclinical substances were under review at Vienna-based dedicated biotech companies in 2014. Vienna
is not only Austria’s hot spot in the pharmaceutical industry, but also the sales force for the global medical device industry which profits
from its optimal geographical location in the middle of Europe. More than 16% of Vienna’s medical device companies perform research,
development and manufacturing. The largest activity area of the dedicated medical device companies in Vienna is the development of
specialized software and other products for telemedicine and e-health solutions. Additionally, outstanding expertise regarding the devel-
opment and production of electromechanical medical devices and assistive products for people with disabilities is available
As the report clearly shows, Vienna is Austria’s scientific powerhouse in the life sciences with research and education activities covering
a broad spectrum of topics from applied biotechnology and medical engineering to human and veterinary medicine and molecular biol-
ogy. Indeed, more than 32,800 life science students are currently enrolled in Vienna`s universities and research institutes, thereby estab-
lishing a talent pool for both academia and business. The city is also home to experienced partners for clinical research and a perfect
meeting place for medical experts from all over the world.
We hope that we have succeeded in arousing your interest. Enjoy
reading and remember: Starting-up in the heart of Europe and
expanding to Vienna pays off!
Johannes Sarx Peter Halwachs
LISAvienna Executive Board
5
6
Content
Overview 8
______________________________________________________________________________________
Life Sciences in Vienna at a Glance ___________________________________________________________ 10
Vienna is Special ________________________________________________________________________________ 14
Tailored Support ________________________________________________________________________________ 15
LISAvienna – Connecting Life Sciences ______________________________________________________ 16
In Detail 18
_____________________________________________________________________________________
Hot Spots in Vienna ____________________________________________________________________________ 18
Life Science Companies in Vienna ____________________________________________________________ 20
Biotech/Pharma in Vienna _____________________________________________________________________ 24
Medical Devices in Vienna _____________________________________________________________________ 30
Spotlight on Academic Research and Education ____________________________________________ 36
Clinical Expertise awaits Partners ______________________________________________________________ 40
Directory 43
____________________________________________________________________________________
Biotech/Pharma Companies ___________________________________________________________________ 45
Research, Development & Manufacturing _______________________________________________ 45
Sales & Distribution ________________________________________________________________________ 69
Medical Device Companies ____________________________________________________________________ 89
Research, Development & Manufacturing _______________________________________________ 89
Sales & Distribution ________________________________________________________________________ 99
Suppliers ________________________________________________________________________________________ 133
Service Providers _______________________________________________________________________________ 155
Academic Research and Education __________________________________________________________ 195
Other Organizations ____________________________________________________________________________ 201
Methodology ________________________________________________________ 213
Index __________________________________________________________________ 221
Annex _________________________________________________________________ 227
Focus of Dedicated Medical Device Companies in Vienna ________________________________227
Focus of Dedicated Medical Biotech Companies in Vienna ________________________________228
7
Vienna –
Life Science Hub
at the Heart of
Europe
8